Blood glucose and pressure controls in diabetic kidney disease: narrative review of adherence, barriers and evidence of achievement
Article
Gardiner, Fergus William, Nwose, Ezekiel Uba, Bwititi, Phillip Taderera, Crockett, Judith and Wang, Lexin. 2018. "Blood glucose and pressure controls in diabetic kidney disease: narrative review of adherence, barriers and evidence of achievement." Journal of Diabetes and Its Complications. 32 (1), pp. 104-112. https://doi.org/10.1016/j.jdiacomp.2017.09.008
| Article Title | Blood glucose and pressure controls in diabetic kidney disease: narrative review of adherence, barriers and evidence of achievement |
|---|---|
| ERA Journal ID | 16358 |
| Article Category | Article |
| Authors | Gardiner, Fergus William, Nwose, Ezekiel Uba, Bwititi, Phillip Taderera, Crockett, Judith and Wang, Lexin |
| Journal Title | Journal of Diabetes and Its Complications |
| Journal Citation | 32 (1), pp. 104-112 |
| Number of Pages | 9 |
| Year | 2018 |
| Publisher | Elsevier |
| Place of Publication | United States |
| ISSN | 1056-8727 |
| 1873-460X | |
| Digital Object Identifier (DOI) | https://doi.org/10.1016/j.jdiacomp.2017.09.008 |
| Web Address (URL) | http://www.jdcjournal.com/article/S1056-8727(17)31076-0/fulltext |
| Abstract | Diabetes mellitus (DM) and hypertension (HT) are two of the most common causes of chronic kidney disease (CKD). CKD is a global problem, leading to increased patient mortality. If CKD is detected early and managed appropriately, then deterioration can be reduced. Appropriate management includes adherence to BP and glycaemia recommendations. This article reviews the epidemiology and the clinical evidence regarding achieving blood pressure (BP) and blood glucose control in patients with CKD and DM, with emphasis on adherence and barriers within the context of Australian clinical guidelines. This article then considers Australian services aimed at BP, DM, and CKD, guideline adherence and control. Evidence from PubMed-listed articles published between 1994 and 2016 is considered, including original research, focusing on randomised controlled trials and prospective studies, review articles, meta- analyses, expert and professional bodies’ guidelines as well as our experience. Our review of the literature, shows that there have been no Australian studies that consider adherence to BP control in DM and CKD patients. This is a major limitation in preventing DM and renal disease progression. It is possible that Australian clinicians are not adhering to DM, HT, and glucose recommendations, thus resulting in reduced patient outcomes. It is hoped that future studies ascertain the extent to which the required BP and glucose control in patients is achieved, and the potential barriers to adherence. The significance of this is immense since the impact of failure to control blood glucose levels and BP leads to renal damage. By understanding the barriers to control, targeted interventions, with the aim of improving patient outcomes, can be developed |
| Keywords | Clinical management; Diabetes mellitus; Hypertension; Renal disease; Chronic kidney disease |
| Contains Sensitive Content | Does not contain sensitive content |
| ANZSRC Field of Research 2020 | 420605. Preventative health care |
| Public Notes | Files associated with this item cannot be displayed due to copyright restrictions. |
| Byline Affiliations | Charles Sturt University |
| Calvary Public Hospital, Australia |
Permalink -
https://research.usq.edu.au/item/z1y35/blood-glucose-and-pressure-controls-in-diabetic-kidney-disease-narrative-review-of-adherence-barriers-and-evidence-of-achievement
21
total views0
total downloads2
views this month0
downloads this month